Labs / Assays & in vitro testing
Parabilis Medicines
Cambridge, MA, United States · parabilismed.com
Parabilis Medicines is a biotechnology company developing ultra-tunable peptide therapeutics based on its Helicon platform. It focuses on discovering and advancing medicines for serious diseases, including cancer and other hard-to-treat targets, from Cambridge, Massachusetts.
Their website has a general contact form; we send your quote request through it.
What they offer
Helicon drug discovery platform
Integrates AI, physics-based computational modeling, high-throughput peptide synthesis, and experimental screening to discover and develop drug candidates.
Helicon design and optimization
Uses computational methods and experimental validation to design and optimize stabilized helical peptide therapeutics for difficult targets.
Multiplexed display screening
Uses multiplexed display screening to systematically explore and identify Helicon candidates.
Co-optimization platform
Applies integrated experimental and computational workflows to co-optimize Helicon therapeutic properties.
What they work on
- Modalities
- Small molecule, Antibody, Peptide
- Assays and studies
- high-throughput peptide synthesis, experimental screening, multiplexed display screening, co-optimization, AI- and physics-based computational modeling
- Scale and capacity
- millions of data points, hundreds of thousands of Helicons, dozens of drug-like properties
- Therapeutic areas
- serious diseases, cancer
- Sites
- Cambridge, United States
- Address
- 9510 Cambridge Discovery Park 30 Acorn Park Drive, Cambridge, MA 02140
Similar labs. Aurigene Pharmaceutical Services, Avantia Labs, Biofidus GmbH, Bioklone Biotech Private Limited
Found in a contract services directory. Listing built from parabilismed.com. Work here? Claim this listing.